Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.17M Sell
3,099
-269
-8% -$428K 2.44% 11
2026
Q1
$4.45M Sell
3,368
-388
-10% -$532K 1.94% 16
2025
Q4
$4.02M Buy
+3,756
New +$3.92M 1.58% 16

Other funds holding ASML

Cane Capital Partners's ASML Position: Q2 2026 in Review

Cane Capital Partners reduced its ASML (ASML) stake by 8% in Q2 2026, selling an estimated $428K and leaving 3,099 shares worth $6.17M. The position accounts for 2.44% of the portfolio, ranked #11.

Cane Capital Partners first reported a position in ASML in Q4 2025 and has held it in 3 quarters since. 2,490 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Cane Capital Partners held 3,099 shares of ASML worth $6.17M as of Q2 2026.
  • Cane Capital Partners sold 269 ASML shares in Q2 2026, an estimated $428K.
  • ASML made up 2.44% of Cane Capital Partners's portfolio in Q2 2026, its #11 holding.
  • Cane Capital Partners first reported a position in ASML in Q4 2025 and has held it in 3 quarters since.
  • 2,490 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Cane Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.